Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2024 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $5.4 billion (+8.5%)
Orthopedics: $2.3 billion (+7.9%)
Hips: $428 million (+8.9%)
Knees: $602 million (+7.1%)
Spine: $307 million (+3.8%)
Net gain: $825 million
Total sales: $1.9 billion (+3.9%)
Hips: $506.6 million (+0.4%)
Knees: $801.1 million (+3.9%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $469.5 million (+6.1%)
Net earnings: $242.8 million
Total sales: $22.4 billion (+4.3%)
Orthopedic: $2.3 billion (+2.1%)
Spine, sports and other: $743 million (-3.1%)
Hips: $417 million (+4.9%)
Knees: $394 million (+8.4%)
Net earnings: $4.7 billion